Liver‐related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets

Author:

Shah Syed Hassan Bin Usman1ORCID,Alavi Maryam1ORCID,Hajarizadeh Behzad1ORCID,Matthews Gail1,Valerio Heather1,Dore Gregory J.1

Affiliation:

1. The Kirby Institute UNSW Sydney Sydney New South Wales Australia

Abstract

AbstractRoutinely collected and linked healthcare administrative datasets could be used to monitor mortality among people with hepatitis B (HBV) and C (HCV). This study aimed to evaluate the concordance in records of liver‐related mortality among people with an HBV or HCV notification, between data on hospitalization for end‐stage liver disease (ESLD) and death certificates. In New South Wales, Australia, HBV and HCV notifications (1993–2017) were linked to hospital admissions (2001–2018), all‐cause mortality (1993–2018) and cause‐specific mortality (1993–2016) datasets. Hospitalization for ESLD was defined as a first‐time hospital admission due to decompensated cirrhosis (DC) or hepatocellular carcinoma (HCC). Consistency of liver death definition of mortality following hospitalization for ESLD was compared with two death certificate‐based definitions of liver deaths coded among primary and secondary cause‐specific mortality data, including ESLD‐related (deaths due to DC and HCC) and all‐liver deaths (ESLD‐related and other liver‐related causes). Of 63,292 and 107,430 individuals with an HBV and HCV notification, there were 4478 (2.6%) post‐ESLD hospitalization deaths, 5572 (3.3%) death certificate liver disease deaths and 2910 (1.7%) death certificate ESLD deaths. Between 2001 and 2016, among HBV post‐ESLD hospitalization deaths (n = 891), 63% (562) had death certificate ESLD recorded, and 83% (741) had death certificate liver disease recorded. Between 2001 and 2016, among HCV post‐ESLD hospitalization deaths (n = 3587), 58% (2082) had death certificate ESLD recorded, and 87% (3135) had death certificate liver disease recorded. At least one‐third of death certificates with DC and HCC as cause of death had no mention of HBV, HCV or viral hepatitis. Our study identified limitations in estimating and tracking HBV and HCV liver disease mortality using death certificate‐based data only. The optimum data for this purpose is either ESLD hospitalisations with vital status information or a combination of these with cause‐specific death certificate data.

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3